Sign up USA
Proactive Investors - Run By Investors For Investors

Unilife soars on licensing deal with Amgen

Other interested parties have been told they are out of luck after Unilife decided on Amgen as its partner
Unilife soars on licensing deal with Amgen
Shares in Unilife were the top performers on Nasdaq

Shares in medtech firm Unilife (NASDAQ:UNIS) soared after it penciled in a licensing deal with Amgen (NASDAQ:AMGN).

The company had previously announced a review of potential strategic alternatives, but appears now to have made its mind up to get into bed with Amgen, having entered into an exclusivity agreement with the biotech giant.

Amgen has stumped up a non-refundable US$15mln deposit in return for a perpetual, worldwide non-exclusive license to use Unilife wearable injector devices for use with certain large volume drug products of Amgen.

In addition, Amgen has been granted a perpetual, worldwide exclusive license to develop, manufacture and supply Unilife's one millilitre (1ml) wearable injector for use with certain small volume drug products, most of which will be developed and manufactured by Unilife.

Unilife will receive an amount for each device it manufactures for Amgen, based on annual volumes and device features, though Amgen will be able to outsource up to 20% of the production, albeit while paying a royalty to Unilife on each device.

Shares in Unilife were the top performers on Nasdaq, jumping 58% to 78.01 cents.

View full UNI profile View Profile

Unilife Medical Solutions Limited Timeline

Newswire
February 22 2016

Related Articles

1504120610_biotechLatest.jpg
August 31 2017
The company is poised for a milestone-rich period over the next year or so
stem cell
June 12 2017
"With multiple value upside triggers ahead, including imminent maiden revenues from CellPlan, I very much look forward to the opportunities ahead" - CEO João Andrade
the word antioxidant
August 15 2017
The heparin test is the firm’s lead product; however the company’s OxiChek device for oxidative stress is also gaining traction
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use